Stephen Baylin

21 results.

November 1, 2022 Combining two cancer medications may increase survival in relapsed myelodysplastic syndrome, lays groundwork for future cancer therapies

GRAND RAPIDS, Mich. (Nov. 1, 2022) — A pair of cancer medications that act as a one-two punch against malignant cells demonstrated increased survival in…

September 22, 2021 Coriell Institute for Medical Research, Van Andel Institute awarded estimated $12.4 million SPORE grant from National Cancer Institute

Estimated at $12.4 million, this five-year grant supports a nationwide team of researchers investigating epigenetic therapies for cancer The Coriell Institute for Medical Research and…

January 13, 2021 A look back at 2020

The past year has challenged us in new and unexpected ways. Yet through it all, we have been inspired by the strength and resilience of…

June 22, 2020 Van Andel Institute scientists win Team Science Awards from American Association for Cancer Research

GRAND RAPIDS, Mich. (June 22, 2020) — The American Association for Cancer Research has awarded Van Andel Institute Professor Peter W. Laird, Ph.D., Director’s…

April 4, 2019 Blocking epigenetic “Swiss army knife” may be a new strategy for treating colorectal cancer

GRAND RAPIDS, Mich. (April 4, 2019) — A new study out today in Cancer Cell shows that blocking specific regions of a protein called…

December 21, 2018 Three Van Andel Research Institute scientists named to list of most cited researchers in the world

GRAND RAPIDS, Mich. (Dec. 21, 2018) — Van Andel Research Institute-affiliated scientists Peter W. Laird, Ph.D., Stephen B. Baylin, M.D., and H. Eric Xu, Ph.D.,…

May 9, 2018 Fighting cancer is a team effort

By Dr. Peter A. Jones and Dr. Steve Baylin Co-leaders, Van Andel Research Institute–Stand Up To Cancer Epigenetics Dream Team Four years ago, we embarked…

December 21, 2017 10 highlights: A look back at 2017

With 2017 quickly coming to close, we’d like to reflect on all that’s been accomplished by rounding up some of this year’s most notable stories…